A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The issue of endocrine disrupting chemicals (EDCs) is receiving wide attention from both the scientific and regulatory communities. Recent analyses of the EDC literature have been criticized for failing to use transparent and objective approaches to draw conclusions about the strength of evidence linking EDC exposures to adverse health or environmental outcomes. Systematic review methodologies are ideal for addressing this issue as they provide transparent and consistent approaches to study selection and evaluation. Objective methods are needed for integrating the multiple streams of evidence (epidemiology, wildlife, laboratory animal, in vitro, and in silico data) that are relevant in assessing EDCs. METHODS: We have developed a framework for the systematic review and integrated assessment (SYRINA) of EDC studies. The framework was designed for use with the International Program on Chemical Safety (IPCS) and World Health Organization (WHO) definition of an EDC, which requires appraisal of evidence regarding 1) association between exposure and an adverse effect, 2) association between exposure and endocrine disrupting activity, and 3) a plausible link between the adverse effect and the endocrine disrupting activity. RESULTS: Building from existing methodologies for evaluating and synthesizing evidence, the SYRINA framework includes seven steps: 1) Formulate the problem; 2) Develop the review protocol; 3) Identify relevant evidence; 4) Evaluate evidence from individual studies; 5) Summarize and evaluate each stream of evidence; 6) Integrate evidence across all streams; 7) Draw conclusions, make recommendations, and evaluate uncertainties. The proposed method is tailored to the IPCS/WHO definition of an EDC but offers flexibility for use in the context of other definitions of EDCs. CONCLUSIONS: When using the SYRINA framework, the overall objective is to provide the evidence base needed to support decision making, including any action to avoid/minimise potential adverse effects of exposures. This framework allows for the evaluation and synthesis of evidence from multiple evidence streams. Finally, a decision regarding regulatory action is not only dependent on the strength of evidence, but also the consequences of action/inaction, e.g. limited or weak evidence may be sufficient to justify action if consequences are serious or irreversible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020124 · Cited by 10,505
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses
Vandenberg, L. N., Colborn, T., Hayes, T. B., Heindel, J. J., Jacobs, D. R., Lee, D.-H., Shioda, T., Soto, A. M., vom Saal, F. S., Welshons, W. V., et al. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1050 · Cited by 3,209 · cited 1×
“(For narrative reviews of the ‘low dose’ literature, see [96, 97].”
BackgroundSelf-citationEDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407 · cited 1×
“Numerous recent reports have summarized the ‘state of the science’ on EDCs [3, 12, 18–22].”
BackgroundSelf-citationGuyatt, G., Oxman, A. D., Sultan, S., Brozek, J., Glasziou, P., Alonso-Coello, P., Atkins, D., Kunz, R., Montori, V., Jaeschke, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.01.006 · Cited by 762
Fu, R., Gartlehner, G., Grant, M., Shamliyan, T., Sedrakyan, A., Wilt, T. J., Griffith, L., Oremus, M., Raina, P., Ismaila, A., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.08.010 · Cited by 730
Authority, E. G. F. T. C. O. S. R. E. F. S. (2010) · EFSA Journal · doi:10.2903/j.efsa.2010.1637 · Cited by 693
Systematic review automation technologies
Tsafnat, G., Glasziou, P., Choong, M. K., Dunn, A., Galgani, F., & Coiera, E. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-74 · Cited by 472 · cited 1×
“are also becoming more acceptable for use [63].”
BackgroundJohnson, P. I., Sutton, P., Atchley, D. S., Koustas, E., Lam, J., Sen, S., Robinson, K. A., Axelrad, D. A., & Woodruff, T. J. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1307893 · Cited by 449 · cited 1×
“Element Explanation Example for perfluorooctanoic acid (PFOA) and birth weight in animals (adapted from [54]) Example for perfluorooctanoic acid (PFOA) and birth weight in humans (adapted from [53])”
BackgroundSelf-citation
Cited by
Haddaway, N. R., Macura, B., Whaley, P., & Pullin, A. S. (2018) · Environmental Evidence · doi:10.1186/s13750-018-0121-7 · Cited by 946
Self-citationOverview of known plastic packaging-associated chemicals and their hazards
Groh, K. J., Backhaus, T., Carney-Almroth, B., Geueke, B., Inostroza, P. A., Lennquist, A., Leslie, H. A., Maffini, M., Slunge, D., Trasande, L., et al. (2019) · Science of The Total Environment · doi:10.1016/j.scitotenv.2018.10.015 · Cited by 913
Endocrine-disrupting chemicals: Implications for human health
Kahn, L. G., Philippat, C., Nakayama, S. F., Slama, R., & Trasande, L. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30129-7 · Cited by 797
Toxicity testing in the 21st century: progress in the past decade and future perspectives
Krewski, D., Andersen, M. E., Tyshenko, M. G., Krishnan, K., Hartung, T., Boekelheide, K., Wambaugh, J. F., Jones, D., Whelan, M., Thomas, R., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-019-02613-4 · Cited by 383
Aidara-Kane, A., Angulo, F. J., Conly, J. M., Minato, Y., Silbergeld, E. K., McEwen, S. A., Collignon, P. J., for the WHO Guideline Development Group, Balkhy, H., Collignon, P., et al. (2018) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-017-0294-9 · Cited by 354
Metadata
- Authors
- Vandenberg, L. N., Ågerstrand, M., Beronius, A., Beausoleil, C., Bergman, Å., Bero, L. A., Bornehag, C.-G., Boyer, C. S., Cooper, G. S., Cotgreave, I., Gee, D., Grandjean, P., Guyton, K. Z., Hass, U., Heindel, J. J., Jobling, S., Kidd, K. A., Kortenkamp, A., Macleod, M. R., Martin, O. V., Norinder, U., Scheringer, M., Thayer, K. A., Toppari, J., Whaley, P., Woodruff, T. J., & Rudén, C.
- Venue
- Environmental Health
- Published
- 2016-07-14
- Volume
- 15
- Issue
- 1
- Pages
- 74-74
- ISSN
- 1476-069X (ISSN-L)
- OpenAlex
- W2467158152
- Cited by
- 123
- References
- 22
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals. https://app.cochat.ai/papers/10.1186/s12940-016-0156-6
- The paper
- Vandenberg, L. N., Ågerstrand, M., Beronius, A., Beausoleil, C., Bergman, Å., Bero, L. A., Bornehag, C.-G., Boyer, C. S., Cooper, G. S., Cotgreave, I., Gee, D., Grandjean, P., Guyton, K. Z., Hass, U., Heindel, J. J., Jobling, S., Kidd, K. A., Kortenkamp, A., Macleod, M. R., . . . Rudén, C. (2016). A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals. Environmental Health. https://doi.org/10.1186/s12940-016-0156-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.